HER2, AR protein expression and chromosomal instability in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)

被引:0
|
作者
Ontiveros, Priscilla [1 ]
Landaverde, Connie [1 ]
Levin, Maren K. [2 ]
Hippely, Sarah [2 ]
Landers, Mark [1 ]
Wang, Yipeng [1 ]
Dittamore, Ryan [1 ]
O'Shaughnessy, Joyce A. [2 ]
机构
[1] Epic Sci, San Diego, CA USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
关键词
D O I
10.1158/1538-7445.AM2019-457
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
457
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Enabling HER2 and androgen receptor (AR) protein expression and localization in circulating tumor cells (CTCs) of ER(+/-)HER2(-) metastatic breast cancer (MBC) patients (pts)
    Ontiveros, P.
    Landaverde, C.
    Graf, R.
    Levin, M. K.
    Hippely, S.
    Wang, Y.
    Landers, M.
    Dittamore, R.
    O'Shaughnessy, J. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] FLUCTUATION OF HER2/NEU PROTEIN LEVELS IN CIRCULATING TUMOR CELLS (CTCS) FROM METASTATIC BREAST CANCER (MBC) PATIENTS (PTS)
    Bessi, S.
    Galardi, F.
    Truglia, M. C.
    Pestrin, M.
    Chiarelli, C.
    Cappadona, S.
    Licitra, S.
    Biganzoli, L.
    Giannini, A.
    ANNALS OF ONCOLOGY, 2009, 20 : 50 - 50
  • [3] Multiple Biomarker Expression in Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients (Pts).
    Somlo, G.
    Hsieh, H. B.
    Curry, D. N.
    Frankel, P.
    Krivacic, R. T.
    Lau, S.
    Lazarus, N.
    Baker, N.
    Swain-Cabriales, S.
    Bruce, R.
    CANCER RESEARCH, 2009, 69 (24) : 649S - 649S
  • [4] Expression of CCR5 associated with HER2 in circulating tumor cells (CTCs) is a novel biomarker for patients with metastatic breast cancer (MBC)
    Zhang, Qiang
    Gerratana, Lorezo
    Shah, Ami N.
    Davis, Andrew A.
    Flaum, Lisa
    Zhang, Youbin
    Pestell, Richard G.
    Wehbe, Firas
    Behdad, Amir
    Platanias, Leonidas
    Gradishar, William
    Cristofanilli, Massimo
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Increased chromatin heterogeneity in circulating tumor cells (CTCs) is associated with high levels of HER2 expression in metastatic breast cancer (MBC)
    Zhang, Qiang
    Gerratana, Lorenzo
    Shah, Ami N.
    Davis, Andrew Adam
    Flaum, Lisa
    Zhou, Xiang
    Zhang, Youbin
    Backman, Vadim
    Behdad, Amir
    Wehbe, Firas
    Gradishar, William
    Platanias, Leonidas
    Cristofanilli, Massimo
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Expression of truncated HER2 receptor in circulating tumor cells (CTCs) of breast cancer patients
    Kallergi, Galaktia
    Nasias, Dimitris
    Papadaki, Maria A.
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Agelaki, Sophia
    CANCER RESEARCH, 2012, 72
  • [7] Distribution and prognostic role of HER2 status of circulating tumor cells (CTCs) and tumor-derived extracellular vesicles (tdEVs) in HER2-metastatic breast cancer (MBC) patients (pts)
    Nicolo, E.
    Munoz-Arcos, L.
    D'Amico, P.
    Zhang, Y.
    Gerratana, L.
    Serafini, M.
    Pontolillo, L.
    Strickland, K.
    Manai, M.
    Davis, A. A.
    Donahue, J.
    Liu, H.
    Gradishar, W. J.
    Shah, A. N.
    Curigliano, G.
    Reduzzi, C.
    Cristofanilli, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S363 - S363
  • [8] Truncated HER2 receptor in circulating tumor cells (CTCs) of early and metastatic breast cancer patients
    Kallergi, G.
    Nasias, D.
    Papadaki, M.
    Mavroudis, D.
    Georgoulias, V.
    Agelaki, S.
    CANCER RESEARCH, 2012, 72
  • [9] EFFICACY OF LAPATINIB (L) IN METASTATIC BREAST CANCER (MBC) PATIENTS (PTS) WITH HER2 NEGATIVE (-) PRIMARY TUMORS (PT) AND HER2 POSITIVE (+) CIRCULATING TUMOR CELLS (CTC)
    Pestrin, M.
    Bessi, S.
    Minisini, A. M.
    Masci, G.
    Cascinu, S.
    Ravaioli, A.
    Di Marsico, R.
    Tondini, C.
    Buyse, M.
    Di Leo, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 41 - 41
  • [10] Circulating tumor cells (CTCs) detect HER2+status and phenotypic heterogeneity in metastatic breast cancer (MBC)
    Austin, Laura
    Mu, Zhaomei
    Avery, Tiffany
    Jaslow, Rebecca
    Paolillo, Carmela
    Toss, Angela
    Fortuna, Paolo
    Zhong, Ye
    Yang, Hushan
    Cristofanilli, Massimo
    CANCER RESEARCH, 2015, 75